SynthesisBMJ global health2025

Pretreatment attrition after rifampicin-resistant tuberculosis diagnosis with Xpert MTB/RIF or ultra in high TB burden countries: a systematic review and meta-analysis.

Christelle Geneviève Jouego et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.